PFBT
AXSM icon

Parkside Financial Bank & Trust’s Axsome Therapeutics AXSM Stock Holding History

Parkside Financial Bank & Trust’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$83K Buy
339
+283
+505% +$61.4K 0.01% 817
2026
Q1 		$9.47K Buy
56
+33
+143% +$5.7K ﹤0.01% 1602
2025
Q4 		$4.2K Hold
23
– – ﹤0.01% 1862
2025
Q3 		$2.79K Hold
23
– – ﹤0.01% 1903
2025
Q2 		$2.4K Buy
23
+8
+53% +$847 ﹤0.01% 1935
2025
Q1 		$1.75K Buy
+15
New +$1.71K ﹤0.01% 1922

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Parkside Financial Bank & Trust's AXSM Position: Q2 2026 in Review

Parkside Financial Bank & Trust increased its Axsome Therapeutics (AXSM) stake by 505% in Q2 2026, buying an estimated $61.4K and bringing the position to 339 shares worth $83K. The position accounts for 0.01% of the portfolio, ranked #817.

Parkside Financial Bank & Trust first reported a position in AXSM in Q1 2025 and has held it in 6 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Parkside Financial Bank & Trust held 339 shares of Axsome Therapeutics worth $83K as of Q2 2026.
  • Parkside Financial Bank & Trust bought 283 Axsome Therapeutics shares in Q2 2026, an estimated $61.4K.
  • Axsome Therapeutics made up 0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #817 holding.
  • Parkside Financial Bank & Trust first reported a position in Axsome Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.